Bioactive Compounds
-
A8326 AZD-54382 CitationTarget: Cyclin-Dependent KinasesSummary: Potent CDK1/2/9 inhibitor -
B6320 1,3-Dipropyl-8-phenylxanthineSummary: A1 adenosine antagonist -
B6606 Telenzepine dihydrochlorideTarget: M1 ReceptorsSummary: muscarinic M1 receptor antagonist -
B6742 N-ArachidonylglycineSummary: Endogenous anandamide-like compound -
B7100 NF 110Summary: P2X3 antagonist -
B7251 WS 12Summary: TRPM8 agonist -
B7452 Src I1Summary: competitive dual site (ATP- and peptide-binding) Src kinase inhibitor -
A8405 Cytarabine1 CitationSummary: cytotoxic agent, blocks DNA synthesis -
B3261 RO4987655Summary: MEK inhibitor -
B1642 WYE-125132 (WYE-132)Target: mTORSummary: ATP-competitive mTOR inhibitor, highly potent

